Ching Ho Chang
Direktor/Vorstandsmitglied bei UNITED BIOPHARMA INC
Profil
Ching Ho Chang is currently an Independent Director at Evergreen International Storage & Transport Corp., a Member-Supervisory Board at H&H Venture Capital Investment Corp., TaiAn Technologies Corp., United Biomedical, Inc. Asia, and United BioPharma, Inc. He previously served as an Independent Director at Tang Eng Iron Works Co. Ltd., an Independent Director at TaiwanJ Pharmaceuticals Co., Ltd., and a Member-Supervisory Board at UBI Pharma Inc. Chang holds a graduate degree from Washington State University and an undergraduate degree from National Cheng Kung University.
Aktive Positionen von Ching Ho Chang
Unternehmen | Position | Beginn |
---|---|---|
UNITED BIOPHARMA INC | Direktor/Vorstandsmitglied | 30.09.2013 |
EVERGREEN INTERNATIONAL STORAGE & TRANSPORT CORPORATION | Direktor/Vorstandsmitglied | 12.06.2014 |
TaiAn Technologies Corp.
TaiAn Technologies Corp. Investment ManagersFinance TaiAn Technologies Corp. operates as a technology advisory company. It specializes in commercializing intellectual properties in the life sciences. The firm identifies and transfers promising technologies from the portfolio companies of the fund into Taiwan and to help catapult the local healthcare related industries up to the global competitive levels. The company was founded in February 2002 and is headquartered in Taipei, Taiwan. | Direktor/Vorstandsmitglied | - |
United Biomedical, Inc. Asia
United Biomedical, Inc. Asia BiotechnologyHealth Technology Part of United Biomedical, Inc., United Biomedical, Inc. Asia is a company based in Taipei, Taiwan that specializes in the research, development, manufacturing, and sales of innovative biotech medical products, particularly vaccines based on synthetic peptides for humans and animals. The Taiwanese company utilizes the core technology of its parent company, UBI, called "UBITh® functional antigenicology," to develop these innovative vaccines. The company offers a range of products, including an anti-IL-6 human vaccine and a COVID-19 vaccine called UB-612. | Direktor/Vorstandsmitglied | - |
H&H Venture Capital Investment Corp. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Ching Ho Chang
Unternehmen | Position | Ende |
---|---|---|
UBI PHARMA INC. | Direktor/Vorstandsmitglied | - |
TANG ENG IRON WORKS CO., LTD. | Direktor/Vorstandsmitglied | - |
TAIWANJ PHARMACEUTICALS CO., LTD. | Direktor/Vorstandsmitglied | - |
Ausbildung von Ching Ho Chang
Washington State University | Graduate Degree |
National Cheng Kung University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
EVERGREEN INTERNATIONAL STORAGE & TRANSPORT CORPORATION | Transportation |
TANG ENG IRON WORKS CO., LTD. | Non-Energy Minerals |
TAIWANJ PHARMACEUTICALS CO., LTD. | Health Technology |
UBI PHARMA INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
H&H Venture Capital Investment Corp. | |
TaiAn Technologies Corp.
TaiAn Technologies Corp. Investment ManagersFinance TaiAn Technologies Corp. operates as a technology advisory company. It specializes in commercializing intellectual properties in the life sciences. The firm identifies and transfers promising technologies from the portfolio companies of the fund into Taiwan and to help catapult the local healthcare related industries up to the global competitive levels. The company was founded in February 2002 and is headquartered in Taipei, Taiwan. | Finance |
United Biomedical, Inc. Asia
United Biomedical, Inc. Asia BiotechnologyHealth Technology Part of United Biomedical, Inc., United Biomedical, Inc. Asia is a company based in Taipei, Taiwan that specializes in the research, development, manufacturing, and sales of innovative biotech medical products, particularly vaccines based on synthetic peptides for humans and animals. The Taiwanese company utilizes the core technology of its parent company, UBI, called "UBITh® functional antigenicology," to develop these innovative vaccines. The company offers a range of products, including an anti-IL-6 human vaccine and a COVID-19 vaccine called UB-612. | Health Technology |
United BioPharma, Inc.
United BioPharma, Inc. Pharmaceuticals: MajorHealth Technology United BioPharma, Inc. engages in the development, manufacture, and sale of monoclonal antibody drug. The company's business activities include the manufacture and sale of western drugs. Its products include trastumab, adalimumab, bevacizumab, rituximab, and omalizumab. The company was founded by Chang Yi Wang on September 30, 2013 and is headquartered in Hsinchu, Taiwan. | Health Technology |